ARCHIVES

GAO: FDA Data On Drug Shortages Inadequate

This article is from The Cancer Letter archive.

Vol. 40 No. 08 | February 21, 2014

Download PDF Visit The Full Archive

Related Articles

Duke Scores Highest On NCAB Review

July 14, 1978

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Olaparib Study Demonstrates No Changes In Overall Survival

March 30, 2012

Sexual Function Affected By Stem Cell Transplant

September 28, 2007

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

Manville Sues U.S. Over “Withheld” Wartime Data

July 22, 1983